Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Genmedica Therapeutics S.L.
DescriptionDual action inhibitor of oxidative stress and inflammation
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today